Translate
Vistagen Therapeutics Inc
About
Vistagen Therapeutics Inc (NASDAQ:VTGN) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Vistagen Receives FDA “Study May Proceed” Letter Under its Refisolone IND Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) due to Menopause
Mar 3 2026
Vistagen to Participate in Upcoming Investor Conferences
Feb 25 2026
Vistagen to Participate in the 46th Annual TD Cowen Healthcare Conference
Feb 12 2026
Vistagen Reports Fiscal Year 2026 Third Quarter Financial Results and Provides Corporate Update
Feb 4 2026
Vistagen to Report Fiscal Year 2026 Third Quarter Results and Host Corporate Update Conference Call on February 12, 2026
Recent Videos
22 abril 26. Noticias acciones biotecnológicas. Resumen diario. #Español #Shorts #diario $XBI #bio
Apr 22, 2026
Comprar acciones de Vistagen Therapeutics Inc: guía rápida (VTGN)
Mar 15, 2026
Vistagen (VTGN) Lawsuit: Investors Claim Phase 3 Risks Were Misrepresented
Mar 13, 2026
Vistagen Therapeutics Q3 2026 Earnings Call
Feb 21, 2026
Financials
Revenue
$789 K
Market Cap
$23.24 M
EPS
-1.90